Suzette O Oyeku

Summary

Affiliation: Montefiore Medical Center
Country: USA

Publications

  1. pmc Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease
    Suzette O Oyeku
    Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
    Pediatr Blood Cancer 60:653-8. 2013
  2. ncbi request reprint Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies
    Suzette O Oyeku
    Division of General Pediatrics, The Children s Hospital at Montefiore, Bronx, New York, USA
    J Natl Med Assoc 102:676-82. 2010

Collaborators

Detail Information

Publications2

  1. pmc Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease
    Suzette O Oyeku
    Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
    Pediatr Blood Cancer 60:653-8. 2013
    ..Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit...
  2. ncbi request reprint Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies
    Suzette O Oyeku
    Division of General Pediatrics, The Children s Hospital at Montefiore, Bronx, New York, USA
    J Natl Med Assoc 102:676-82. 2010
    ..We assessed clinicians' knowledge, confidence, and practices regarding hemoglobinopathy newborn screening, and the effect of mailed educational materials vs interactive seminar on knowledge and confidence...